Literature DB >> 33252884

JAK Inhibition in the Aicardi-Goutières Syndrome.

Bénédicte Neven1, Buthaina Al Adba2, Marie Hully3, Isabelle Desguerre3, Claire Pressiat4, Natalie Boddaert3, Darragh Duffy5, Gillian I Rice6, Luis Seabra7, Marie-Louise Frémond7, Stéphane Blanche3, Yanick J Crow8.   

Abstract

Mesh：

Substances：

Year:  2020        PMID： 33252884     DOI： 10.1056/NEJMc2031081

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  6 in total

1.  DNA damage contributes to neurotoxic inflammation in Aicardi-Goutières syndrome astrocytes.

Authors:  Marco Luciani; Francesca Gatto; Monah Abou Alezz; Anna Maria Sole Giordano; Chiara Beghè; Lucrezia Della Volpe; Alessandro Migliara; Sara Valsoni; Marco Genua; Monika Dzieciatkowska; Giacomo Frati; Julie Tahraoui-Bories; Silvia Clara Giliani; Simona Orcesi; Elisa Fazzi; Renato Ostuni; Angelo D'Alessandro; Raffaella Di Micco; Ivan Merelli; Angelo Lombardo; Martin A M Reijns; Natalia Gromak; Angela Gritti; Anna Kajaste-Rudnitski
Journal:  J Exp Med       Date:  2022-03-09       Impact factor: 14.307

Review 2.  The type I interferonopathies: 10 years on.

Authors:  Yanick J Crow; Daniel B Stetson
Journal:  Nat Rev Immunol       Date:  2021-10-20       Impact factor: 108.555

Review 3.  Lung Inflammation in STING-Associated Vasculopathy with Onset in Infancy (SAVI).

Authors:  Clémence David; Marie-Louise Frémond
Journal:  Cells       Date:  2022-01-18       Impact factor: 6.600

4.  Janus Kinase Inhibitors in the Treatment of Type I Interferonopathies: A Case Series From a Single Center in China.

Authors:  Wendao Li; Wei Wang; Wei Wang; Linqing Zhong; Lijuan Gou; Changyan Wang; Jingran Ma; Meiying Quan; Shan Jian; Xiaoyan Tang; Yu Zhang; Lin Wang; Mingsheng Ma; Hongmei Song
Journal:  Front Immunol       Date:  2022-03-28       Impact factor: 7.561

Review 5.  Impact of JAK Inhibitors in Pediatric Patients with STAT1 Gain of Function (GOF) Mutations-10 Children and Review of the Literature.

Authors:  Olaf Neth; Peter Olbrich; Angela Deyà-Martínez; Jaques G Rivière; Pérsio Roxo-Junior; Jan Ramakers; Markéta Bloomfield; Paloma Guisado Hernandez; Pilar Blanco Lobo; Soraya Regina Abu Jamra; Ana Esteve-Sole; Veronika Kanderova; Ana García-García; Mireia Lopez-Corbeto; Natalia Martinez Pomar; Andrea Martín-Nalda; Laia Alsina
Journal:  J Clin Immunol       Date:  2022-04-29       Impact factor: 8.542

6.  Ruxolitinib in Aicardi-Goutières syndrome.

Authors:  Eleonora Mura; Silvia Masnada; Clara Antonello; Cecilia Parazzini; Giana Izzo; Jessica Garau; Daisy Sproviero; Cristina Cereda; Simona Orcesi; Pierangelo Veggiotti; Gianvincenzo Zuccotti; Dario Dilillo; Francesca Penagini; Davide Tonduti
Journal:  Metab Brain Dis       Date:  2021-03-15       Impact factor: 3.584
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.